- UroToday Home
- Urologic Oncology
The Latest Renal Cancer Research
Recent Abstracts
-
Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma.Renal CancerJune 18, 2021
-
Active surveillance in renal tumors: Clinical and oncological outcomes.Renal CancerJune 18, 2021
-
Germline Variants in Renal Cell Carcinoma Patients - Expert CommentaryRenal CancerJune 17, 2021
-
Adrenalectomy During Radical Nephrectomy- Incidence and Oncologic Outcomes from the Canadian Kidney Cancer Information System (CKCis) -A Modern Era, Nationwide, Multicenter Cohort.Renal CancerJune 17, 2021
-
Differential effect of body mass index by gender on oncological outcomes in patients with renal cell carcinoma.Renal CancerJune 17, 2021
-
Real-world Clinical Effectiveness of Lenvatinib/Everolimus in a Heavily Pretreated Advanced/Metastatic Renal Cell Carcinoma Population in the US Community Oncology Setting.Renal CancerJune 16, 2021
-
Gene expression signature correlates with outcomes in metastatic renal cell carcinoma patients treated with everolimus alone or with a vascular disrupting agent.Renal CancerJune 16, 2021
-
Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-up: AUA Guideline: Part II.Renal CancerJune 15, 2021
-
Assessment of predictors of renal cell carcinoma progression after nephrectomy at short and intermediate term follow-up and implication on surveillance protocols.Renal CancerJune 15, 2021
-
Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline Part I.Renal CancerJune 14, 2021
Beyond the Abstracts
-
Does Reduced Renal Function Predispose to Cancer-specific Mortality from Renal Cell Carcinoma? - Beyond the AbstractRenal CancerJune 17, 2021
-
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-Institutional Registry (REMARCC) - Beyond the AbstractRenal CancerMay 18, 2021
-
Race/Ethnicity Determines Life Expectancy in Surgically Treated T1aN0M0 Renal Cell Carcinoma Patients - Beyond the AbstractRenal CancerMay 11, 2021
-
HIF2-Plk1, an Oncogenic Pathway in Clear Cell Renal Cell Carcinoma - Beyond the AbstractRenal CancerMay 3, 2021
-
Diagnostic Approach in TFE3-Rearranged Renal Cell Carcinoma: A Multi-Institutional International Survey - Beyond the AbstractRenal CancerApril 19, 2021
-
Available Active Surveillance Follow-up Protocols for Small Renal Mass: A Systematic Review - Beyond the AbstractRenal CancerApril 12, 2021
-
Novel Liquid Biomarkers and Innovative Imaging for Kidney Cancer Diagnosis: What Can Be Implemented in Our Practice Today? a Systematic Review of the Literature - Beyond the AbstractRenal CancerApril 5, 2021
-
Low-Dose Nivolumab in Renal Cell Carcinoma: A Real-World Experience - Beyond the AbstractRenal CancerMarch 24, 2021
-
Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United States - Beyond the AbstractRenal CancerJanuary 19, 2021
-
Pushing the Limits of Metastasis-Directed Treatment in Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy - Beyond the AbstractRenal CancerJanuary 11, 2021